Claims for Patent: 7,632,494

Summary for Patent: 7,632,494

Title:	Methods for enlarging the diameter of a biological conduit in a human subject
Abstract:	The invention provides methods for treating an obstructed biological conduit that include administering to the conduit an agent that can degrade extracellular matrix of obstructing tissue. Particular methods include delivery of an enzyme or a mixture of several enzymes to the area or region of obstruction wherein the enzyme(s) have the capability to degrade extracellular matrix components within the obstruction thereby restoring the normal flow of transported fluid through the conduit. The invention also includes prophylactically dilating a section of conduit to minimize the risk of obstruction formation.
Inventor(s):	Franano; F. Nicholas (Kansas City, MO)
Assignee:	Proteon Therapeutics, Inc. (Kansas City, MO)
Application Number:	12/082,517
Patent Claims:	1. A method for therapeutically increasing the diameter of a biological conduit comprising elastin in a mammalian subject in need thereof, the method comprising: locally administering to the wall of the biological conduit a composition comprising an elastase in a dose sufficient to increase the diameter of the biological conduit. 2. The method of claim 1, wherein said biological conduit is selected from the group consisting of a blood vessel, a bile duct, a ureter, a pancreatic duct, and a bronchus. 3. The method of claim 1, wherein said mammalian subject is human. 4. The method of claim 1, wherein said mammalian subject is in need of prophylactic treatment. 5. The method of claim 1, wherein said elastase is a pancreatic elastase. 6. The method of claim 1, wherein said composition does not comprise a collagenase. 7. The method of claim 1, wherein said elastase is admixed with a pharmaceutically acceptable carrier. 8. The method of claim 1, further comprising administering mechanical dilation to said biological conduit. 9. The method of claim 8, wherein said mechanical dilation is effected by a balloon catheter. 10. The method of claim 1, 3, 4, 5, 6, 2, 8, or 9, wherein said composition is administered into the wall of the biological conduit. 11. The method of claim 1, 3, 4, 5, 6, 7, 8, or 9, wherein said composition is administered to the exterior of the biological conduit. 12. The method of claim 1, 3, 4, 5, 6, 2, 8, or 9, wherein said administering is performed via a catheter. 13. The method of claim 12, wherein a portion of said catheter is inserted into the wall of the biological conduit.

Details for Patent 7,632,494

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2019-09-24